ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Evotec and Odyssey Therapeutics entered an AI-enabled research and development collaboration targeting autoimmune and inflammatory diseases. The partnership applies artificial intelligence to advance drug discovery programs in these therapeutic areas.
Tap to vote and see what everyone thinks.
Summary by ByteBrief